Recombinant Rat MME Protein，GST

The study of MME (membrane metalloendopeptidase), also known as neprilysin, is vital due to its significant role in maintaining various physiological functions and its implications in several pathological conditions. MME is a zinc-dependent metalloprotease that hydrolyzes a broad range of bioactive peptides, including neuropeptides and vasoactive peptides, thereby influencing processes such as blood pressure regulation, neurodegeneration, and inflammation. Its activity is particularly critical in the degradation of amyloid-beta peptides, linking it to Alzheimer’s disease pathology. Researchers have focused on understanding the structural and functional properties of MME to develop potential therapeutic strategies. Given the enzyme’s involvement in neurodegenerative disorders, selective inhibitors of MME have emerged as potential candidates for enhancing cognitive function and mitigating disease progression. Additionally, MME's expression levels and activity are associated with various cancers, further expanding the scope of its research as a biomarker or therapeutic target. Efforts are also directed toward elucidating the regulatory mechanisms governing MME expression and activity, which could inform strategies for modulating its function in clinical settings. Overall, the multifaceted role of MME in health and disease underscores the importance of ongoing research to exploit its potential in therapeutic interventions.